While there are no accurate estimates of the prevalence and pathogenicity of mosaic KRAS mutations in human, it is possible that a proportion of cancer-free individuals with detectable low allelic fractions mutations in circulating DNA could reflect somatic mosaicism. Here, KRAS is linked to cancer.